Related Experiment Video

Updated: Nov 9, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

586

MicroRNAs and Their Roles in Breast Cancer Bone Metastasis

Margherita Puppo1, Manoj K Valluru2, Philippe Clézardin3,4

  • 1Oncology and Metabolism Department (OMD), Medical School, University of Sheffield, Sheffield, UK. m.puppo@sheffield.ac.uk.

Current Osteoporosis Reports
|April 8, 2021
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in breast cancer bone metastasis. This review explores their role, therapeutic potential, and use as biomarkers for early diagnosis and tailored treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bone metastasis is a critical complication of advanced breast cancer, significantly impacting patient prognosis and quality of life.
  • Current therapeutic strategies for bone metastasis offer limited palliative benefits, underscoring the need for novel, effective treatment targets.
  • MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly recognized for their involvement in cancer progression, including bone metastasis.

Purpose of the Study:

  • To review recent advancements concerning the role of miRNAs and their messenger RNA (mRNA) targets in the development and progression of breast cancer bone metastasis.
  • To explore the potential of miRNAs as direct therapeutic agents or as components of advanced treatment strategies for bone metastasis.
  • To evaluate the utility of miRNAs as predictive biomarkers for early detection and personalized therapy in breast cancer patients with bone metastasis.

Main Methods:

  • Comprehensive literature search of recent studies on miRNAs, mRNA targets, and breast cancer bone metastasis.
  • Analysis of findings related to the functional roles of specific miRNAs in the metastatic process.
  • Synthesis of information regarding the therapeutic and diagnostic applications of miRNAs in this context.

Main Results:

  • Specific miRNAs and their mRNA targets are significantly associated with various stages of breast cancer bone metastasis.
  • miRNAs demonstrate potential as both therapeutic targets and novel treatment modalities for bone metastasis.
  • miRNAs show promise as predictive biomarkers for early diagnosis and personalized treatment strategies.

Conclusions:

  • MicroRNAs play a crucial role in driving breast cancer bone metastasis through the regulation of specific mRNA targets.
  • miRNAs offer promising avenues for developing targeted therapies and advanced treatment strategies for bone metastasis.
  • The potential of miRNAs as predictive biomarkers could lead to earlier diagnosis and more effective, tailored treatments for patients.
Keywords:
BiomarkersBone metastasisBreast cancerMicroRNAsmiRNA therapy

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.0K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

110

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.7K